inupadenant

N/A

Report date: 2024/06/27 20:00:09
NME

Base Information

Drug Nameinupadenant
Drug Alias NameEOS-85​​0EOS-100850
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2 receptor antagonists
TargetsAdenosine A2 receptor
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIteos
China Registration ClassN/A

Develop Information

Active CompaniesITeos Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A